Featured Research

from universities, journals, and other organizations

Cell of origin for brain tumors may predict response to therapy

Date:
December 17, 2010
Source:
University of California - San Francisco
Summary:
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. Scientists have identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.

An oligodendroglioma is visible in the large area that appears slightly lighter, on the left side of the image.
Credit: University of Rochester Medical Center

For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma. This distinction explains why oligodendroglioma is more responsive to therapy than other brain tumors such as glioblastoma multiforme.

The finding is significant, the researchers say, because it gives cancer doctors and researchers new cellular pathways to target in developing therapies. It also updates current beliefs -- that brain tumors derive from neural stem cells -- with the indication that, since oligodendroglioma derives from progenitor cells, stem cell-specific therapies may not hold promise for treating those types of brain tumors.

Different life expectancies for two types of brain tumors were what first piqued the scientists' interest.

"With treatment, patients with oligodendroglioma can live many years longer than patients with gliobastoma multiforme. For two types of tumor that appear similar, the outcome is so different. We were interested in understanding this," said William A. Weiss, MD, PhD, corresponding author and professor in the Departments of Neurology, Pediatrics and Neurological Surgery.

"There has been a great deal of research into the molecular basis of glial tumors, but current therapies have not advanced much. Many remain ineffective and the majority of patients die from the disease, so fresh strategies are desperately needed. The ability we now have to sub-classify tumors and differentiate gliomas based on differences in cell of origin will be helpful in the search for more effective treatments," Weiss added.

Findings are described in the December 14 issue of the journal Cancer Cell.

Glioblastomas arise from the glial cells in the brain and are known to be highly aggressive, resulting in a life expectancy of just six to 12 months after diagnosis, according to the National Brain Tumor Society. Glial and neuronal cells both arise from progenitor cells, which in turn arise from neural stem cells. Oligodendrglial cells are a type of glial cell that supports neuronal cells, insulating them by producing myelin, a substance that promotes communication between neurons.

"Our study shows that tumors can arise from either neural stem cells or progenitor cells, which produce different types of brain cancers that exhibit different responses to therapy," Weiss said.

Using MRI and detailed analyses of both human and mouse tumors, the team discovered that tumor cells differentiate in the brain in two key ways, and the mode of differentiation impacts whether the tumor will be sensitive to therapy. Tumors that arise from neural stem cells such as astrocytomas (of which glioblastoma is the most common) are less sensitive to therapy because dormant stem cell-like tumor cells do not divide unless provoked by certain factors. Tumors that arise from progenitor cells, such as oligodendroglioma, are more sensitive to therapy because progenitor cells are actively dividing.

"These results suggest that oligodendroglioma tumor cells arise from normal oligodendrocyte progenitor cells, and that a progenitor rather than a neural stem cell origin underlies improved prognosis in patients with this tumor," said lead author Anders I. Persson, PhD, assistant professor of Neurology in UCSF's Helen Diller Family Comprehensive Cancer Center.

Since oligodendrogliomas are more sensitive to therapy, the team hypothesized that this sensitivity might be a property of the glial progenitors from which they arise. To test this, they treated stem cells, astrocytomas, progenitors and oligodendrogliomas with the chemotherapeutic used for glioma treatment, temozolomide. They found that stem cells and astrocytoma cells were largely resistant to the drug, but the growth of oligodendroglioma cells and of glial progenitors was vastly stalled.

"By studying the properties and behavior of the precursor cells, we have better clues about which cellular pathways could be effective for therapy, depending on the type of tumor," Persson said. "So for instance, now that we know to determine whether a brain tumor is a progenitor disease or stem cell disease, we could use MRI to make these diagnoses, resulting in faster, more effective treatment for glioma patients."

The study was supported by the Swedish Society for Medical Research, Swedish Medical Research Council, Hjarnfonden (the Swedish Brain Foundation), Sandler Postdoctoral Fellowship and the Joel A. Gingras Jr/American Brain Tumor Association Fellowship. Funding was also provided by a Sandler Opportunity Award in Basic Science, National Institutes of Health, Brain Tumor Society, UCSF Academic Senate, Accelerate Brain Cancer Cure and the Burroughs Wellcome Fund.

Additional UCSF authors include Claudia Petritsch, PhD; Fredrik J. Swartling, PhD; Melissa Itsara; David D. Goldenberg; Scott Vandenberg, MD, PhD; Kim N. Nguyen; Stanislava Yakovenko; Jennifer Ayers-Ringler; Mitchel S. Berger, MD; Gabriele Bergers, PhD; and Tracy R. McKnight, PhD.

Authors not affiliated with UCSF include Steven Goldman, MD, PhD, Frasier Sim, PhD and Romane Auvergne, PhD, from the University of Rochester; Akiko Nishiyama from the University of Connecticut; and William B. Stallcup, PhD, from Burnham Institute for Medical Research.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Journal Reference:

  1. Anders I. Persson, Claudia Petritsch, Fredrik J. Swartling, Melissa Itsara, Fraser J. Sim, Romane Auvergne, David D. Goldenberg, Scott R. Vandenberg, Kim N. Nguyen, Stanislava Yakovenko, Jennifer Ayers-Ringler, Akiko Nishiyama, William B. Stallcup, Mitchel S. Berger, Gabriele Bergers, Tracy R. McKnight, Steven A. Goldman, William A. Weiss. Non-Stem Cell Origin for Oligodendroglioma. Cancer Cell, Volume 18, Issue 6, 669-682, 14 December 2010 DOI: 10.1016/j.ccr.2010.10.033

Cite This Page:

University of California - San Francisco. "Cell of origin for brain tumors may predict response to therapy." ScienceDaily. ScienceDaily, 17 December 2010. <www.sciencedaily.com/releases/2010/12/101214141943.htm>.
University of California - San Francisco. (2010, December 17). Cell of origin for brain tumors may predict response to therapy. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2010/12/101214141943.htm
University of California - San Francisco. "Cell of origin for brain tumors may predict response to therapy." ScienceDaily. www.sciencedaily.com/releases/2010/12/101214141943.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins